Structure-Adaptive E-Value Filter for Detecting Regional Signals in Brain Imaging
Structural MRI provides a noninvasive view of the neuroanatomical differences associated with cognitive impairment and dementia. Using data from the Alzheimer's Disease Neuroimaging Initiative, we investigate which anatomical regions exhibit widespread gray-matter differences and how these regional patterns vary across the clinical spectrum. Addressing this goal requires translating spatially dependent voxel-level evidence into regional conclusions while controlling multiplicity across anatomical regions. We propose the Structure-adaptive E-value FilTer (SEFT), which uses flexible working models to construct spatially adaptive voxel-level scores and aggregates them into regional partial-conjunction e-values. When combined with the e-value Benjamini--Hochberg (e-BH) procedure, these e-values provide finite-sample control of the set-wise false discovery rate under arbitrary interregional dependence. The ADNI analysis reveals a coherent neuroanatomical pattern: the exploratory analysis shows that differences between normal cognition and mild cognitive impairment are concentrated in medial-temporal regions, whereas the differences between mild cognitive impairment and dementia extend more broadly into temporal--limbic and posterior association regions. Both patterns largely overlap the normal-cognition--dementia benchmark, identifying a shared anatomical core across the clinical comparisons.
Authors
- Hangjin Jiang (ORCID: https://orcid.org/0000-0002-3905-7325)
- Wenguang Sun
- Jingcheng He
- for the Alzheimer's Disease Neuroimaging Initiative
Institutions
- Zhejiang University (CN)
Publication Details
- Journal
- Journal of the American Statistical Association
- Published
- 2026-09-28
- DOI
- https://doi.org/10.1080/01621459.2026.2735971
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Foundation for the National Institutes of Health
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Biogen
- F. Hoffmann-La Roche
- Meso Scale Diagnostics
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- Novartis Pharmaceuticals Corporation
- Northern California Institute for Research and Education
- National Natural Science Foundation of China
- Eisai
- Servier
- H. Lundbeck A/S
- IXICO
- National Institutes of Health
- Genentech
- Canadian Institutes of Health Research